enVVeno Medical Corp

Company Profile

enVVeno Medical Corp had its IPO on 2018-05-31 under the ticker symbol NVNO.

The company operates in the Healthcare sector and Medical Devices industry. enVVeno Medical Corp has a staff strength of 30 employees.

Stock update

Shares of enVVeno Medical Corp opened at $5.06 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $5.06 - $5.45, and closed at $5.23.

This is a +2.75% increase from the previous day's closing price.

A total volume of 19,711 shares were traded at the close of the day’s session.

In the last one week, shares of enVVeno Medical Corp have increased by +4.6%.

enVVeno Medical Corp's Key Ratios

enVVeno Medical Corp has a market cap of $47.36 million, indicating a price to book ratio of 1.2808 and a price to sales ratio of 0.

In the last 12-months enVVeno Medical Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $-26005000. The EBITDA ratio measures enVVeno Medical Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, enVVeno Medical Corp’s operating margin was 0% while its return on assets stood at -39.96% with a return of equity of -66.72%.

In Q2, enVVeno Medical Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

enVVeno Medical Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.3 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into enVVeno Medical Corp’s profitability.

enVVeno Medical Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.598. Its price to sales ratio in the trailing 12-months stood at 0.

enVVeno Medical Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$32.09 million

Total Liabilities

$2.07 million

Operating Cash Flow

$0

Capital Expenditure

$21000

Dividend Payout Ratio

0%

enVVeno Medical Corp ended 2024 with $32.09 million in total assets and $0 in total liabilities. Its intangible assets were valued at $32.09 million while shareholder equity stood at $28.81 million.

enVVeno Medical Corp ended 2024 with $0 in deferred long-term liabilities, $2.07 million in other current liabilities, in common stock, $-119386000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $4.71 million and cash and short-term investments were $29.76 million. The company’s total short-term debt was $352,000 while long-term debt stood at $0.

enVVeno Medical Corp’s total current assets stands at $30.11 million while long-term investments were $0 and short-term investments were $25.04 million. Its net receivables were $0 compared to accounts payable of $1.30 million and inventory worth $0.

In 2024, enVVeno Medical Corp's operating cash flow was $0 while its capital expenditure stood at $21000.

Comparatively, enVVeno Medical Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$5.23

52-Week High

$7.93

52-Week Low

$2.51

Analyst Target Price

$23

enVVeno Medical Corp stock is currently trading at $5.23 per share. It touched a 52-week high of $7.93 and a 52-week low of $7.93. Analysts tracking the stock have a 12-month average target price of $23.

Its 50-day moving average was $4.61 and 200-day moving average was $4.66 The short ratio stood at 4.04 indicating a short percent outstanding of 0%.

Around 54.1% of the company’s stock are held by insiders while 2869.8% are held by institutions.